Alto Partners SGR
VC Fund
Milano, Italy
Alto Partners SGR is a VC fund in Milano focused on Health Care and Manufacturing. Alto Partners SGR manages independent private equity funds dedicated to the Italian mid-market.Alto Partners SGR pursues an investment strategy oriented to growing and cash-generative companies based in Italy. The Fund predominantly targets buyout transactions, however also selected minority investments areconsidered in companies with strong shareholder protections and pre-determined exit routes.The Team combines more than 125 years financial experience. In particular, the partners each have more than 20 years of professional experience in the Italian and International financial community.Alto Partners SGR assists the portfolio companies on a large number of strategic, operational and financial areas, also thanks to the contribution of qualified senior consultants with specific industry knowledge.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Alto Partners SGR invests in
Stages Alto Partners SGR invests in
Countries Alto Partners SGR invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Investment Focus
Industry
- Health Care 2 (33%)
- Manufacturing 2 (33%)
- Pharmaceutical 2 (33%)
- Medical 1 (17%)
- Shopping 1 (17%)
Stage
- Private Equity 3 (50%)
- Series A 1 (17%)
- Funding Round 1 (17%)
Country
- Italy 4 (67%)
- Indonesia 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Mario Visioni
Partner
|
Partner | Total investments: 0 | Find email | |
Raffaele de Courten
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
|
Stefano Scarpis
Founding Partner
|
Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
C.E.I. High Fidelity Spare Parts
|
CEI is a manufacturer and designer of spare parts for industrial vehicles. The initial product range consisting exclusively of gears for gearboxes and differentials has been widened through the years by introducing spare parts for steering and braking system, suspensions, and engine. | Private Equity / Jun 01, 2022 | |
Mipharm SPA
|
Mipharm was founded in January 1998 by Mr. Giuseppe G. Miglio, who can show more than 40 years of experience in the pharmaceutical world and in Sandoz Holding, where he covered many and growing positions. In 1986 he was appointed to President and Managing Director of Sandoz Prodotti Farmaceutici SpA ; in 1990 he was appointed President and ManagingDirector of Sandoz Holding Italia Spa. In 1996, he managed first the merger between Sandoz and Ciba Geigy and then he was appointed President of Novartis Italy, until he decided to found Mipharm, a new company that in few years has become an important player in pharmaceutical market both in Italy and in Europe. Mipharm acquired from Novartis the production site (former Sandoz facility) based in Milan: starting from its production capacity, many third party production agreements have been signed. Up to 2009, Mipharm developed an integrated business model based on a modern and efficient production site and on a Business Unit Promotion focused on sales & marketing of new and innovative products. | Private Equity / Mar 01, 2022 | |
Diatech Pharmacogenetics
|
Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the years and now owns more than 70% of the Italian molecular diagnostic market and it is rapidly growingworldwide; to date, more than 20.000 diagnostic tests have been performed using its solutions and every year Diatech Pharmacogenetics reinvests 20% of it revenues in R&D.Diatech Pharmacogenetics is able to take pharmacogenetics tests from idea to market on a variety of platforms, from real-time PCR to barcoded microarrays, mass-spectrometry and next generation sequencing, supplying all reagents, instruments, materials and support necessary. Its complete solutions guide diagnostic operators from sample extraction, quality control, molecular assay to bioinformatic analysis and report.The latest products launched include a liquid biopsy cfDNA extraction kit, a real-time PCR system with all reagent provided in a dry and stable format, micro-satellite instability assays and an end-to-end NGS solution that works on both Illumina and IonTorrent platforms.All Diatech products are developed under EN ISO 9001 and EN ISO 13485 and have been designed, developed and validated in accordance with the Directive 98/79/EC on in vitro diagnostic medical devices (CE-IVD). | Private Equity / Jun 07, 2021 | |
|
C.E.I. High Fidelity Spare Parts
|
CEI is a manufacturer and designer of spare parts for industrial vehicles. The initial product range consisting exclusively of gears for gearboxes and differentials has been widened through the years by introducing spare parts for steering and braking system, suspensions, and engine. | Private Equity / Apr 01, 2020 | |
Chilibeli
|
Chilibeli is a social commerce platform that connects manufacturers/farmers with agents directly through various messaging tools.The company empowers farmers and its network of agents to earn extra income with ease and flexibility by streamlining the end-to-end supply chain. It aims to help more local farmers, agents, and consumers benefitfrom the social economy.The company was founded in 2019 by Alex Feng, Damon Yue, and Matt Li. It is based in Setiabudi, Jakarta, | $10M / Series A / Mar 20, 2020 | |
Legami
|
R&D Srl manufactures and markets stationery, bags, diaries, and other accessories. | $7.7M / Oct 13, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Alto Partners SGR invest in?
Alto Partners SGR invests primarily in Health Care, Manufacturing and Pharmaceutical startups, most often at Private Equity and Series A stage. Most of the 6 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alto Partners SGR?
Public channels for Alto Partners SGR include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alto Partners SGR?
The team at Alto Partners SGR includes Mario Visioni (Partner), Raffaele de Courten (Founding Partner) and Stefano Scarpis (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
